Ideally, all eligible patients in a given country should have equal access to clinical trials, independent of geographic location or socio-economic circumstances. Failing that, cross-border access to clinical trials remains an important access road for patients. On this page, updated resources regarding cross-border access to clinical trials will regularly be made available.
Podcast discussion with Katriina Jalkanen (Finland), Ulrik Lassen (Denmark) and Bettina Ryll (Sweden): Cross-border access and continuity of patient care in Europe seen from a medical perspective
Podcast interview with Dr Ingrid Klingmann, Chair of the Board of the European Forum for Good Clinical Practice. An overview of the cross-border situation in EU.
Podcast interview with Belgian cancer patient enrolled in a French clinical trial.
The EU-X-CT inititative aims to bring together reliable and accessible information regarding legal, regulatory and ethical as well as practical aspects on conditions and options for cross-border access to clinical trials with medicinal products.
Official EU website: each EU country has at least one national contact point which can help you with questions about medical treatment in another EU country.